# Neurocognitive Assessment CNSL and LGG

> **NCT07710131** · NA · NOT_YET_RECRUITING · sponsor: **Dana-Farber Cancer Institute** · enrollment: 36 (estimated)

## Conditions studied

- PCNSL
- Brain Tumor
- Cognitive Dysfunction
- IDH Mutation
- Low-grade Glioma

## Interventions

- **BEHAVIORAL:** Digital Cognitive Assessment (TestMyBrain and Mobile Toolbox)
- **BEHAVIORAL:** Traditional Neuropsychological Testing
- **OTHER:** Quality of Life and Mood Questionnaires
- **OTHER:** Brain MRI (Standard of Care)

## Key facts

- **NCT ID:** NCT07710131
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2028-01-01
- **Final completion:** 2029-01-01
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07710131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07710131, "Neurocognitive Assessment CNSL and LGG". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07710131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*